The challenge of cancer induced neuropathic pain
Affiliation
Palliative Medicine, Specialist in neuropathic pain relief, St Raphael’s Hospice, 801, London Road, North Cheam, Surrey, SM3 9DX, UK
Corresponding Author
Marie Joseph, Medical Director and Lead Consultant in Palliative Medicine, Specialist in neuropathic pain relief, St Raphael’s Hospice, 801, London Road, North Cheam, Surrey, SM3 9DX, UK Tel: +44 (0)208 099 7777, Fax: +44 (0)208 099 1724; E-mail: mariejoseph@straphaels.org.uk
Citation
Joseph, M. The Challenge of Cancer Induced Neuropathic Pain. (2016) J Palliat Care Pediatr 1(1): 5- 8.
Copy rights
© 2016 Joseph, M. This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License.
Keywords
Abstract
Neuropathic pain is often the most distressing type of pain that can be suffered by any human being. In the clinical context of cancer, both detection and appropriate management lead not only to improved quality of life but also enables the patient to receive appropriate oncological management.
The clinician needs to be aware of the complex pathophysiology of neuropathic pain which necessitates a rational, multi-modal, poly-pharmacological therapeutic approach in order to maximize efficacy and minimize medication induced toxicity.